## Abstract Biohybrid implalts represent a new class of medical device in which living cells, supported in a hydrogel matrix, and surrounded by semipepmiable membrane, produce and deliver therapeutic reagents tm specific sites wthin a host. First prpmsed in the midβ1970s for tpeatment modality has
Progress technology in microencapsulation methods for cell therapy
β Scribed by Jean-Michel Rabanel; Xavier Banquy; Hamza Zouaoui; Mohamed Mokhtar; Patrice Hildgen
- Publisher
- American Institute of Chemical Engineers
- Year
- 2009
- Tongue
- English
- Weight
- 724 KB
- Volume
- 25
- Category
- Article
- ISSN
- 8756-7938
- DOI
- 10.1002/btpr.226
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In January 2004, following the recommendation of the previously established High Level Group, [1] the European Commission set up the European Hydrogen & Fuel Cell Technology Platform (HFP). This partnership of more than 200 stakeholders is intended to prepare and direct an effective strategy for bri
As Cancer commemorates 50 years of continuous publication, this article is one of a series of summaries on the current status of some of the oncologic issues reported in the first volume in 1948.
## Abstract Hepatocellular carcinoma is one of the most aggressive solid tumours associated with poor prognosis. Despite its significance, there is only an elemental understanding of the mechanisms that drive disease pathogenesis, and there are just limited therapy options. The medical community is